Filing Details
Clene Inc. (NASDAQ:CLNN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:CLNN
Clene Inc. (CLNN) Files Quarterly Report for Q0
Clene Inc. (NASDAQ:CLNN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
At publication ·
What changed
Clene Inc. (NASDAQ:CLNN) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Clene Inc. (NASDAQ: CLNN) filed its quarterly report (Form 10-Q) with the SEC on August 14, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $4.14 with a market capitalization of $64.9 million as of the filing date.
- The article does not disclose Q0 revenue figures, limiting visibility into the company's financial performance for the reported period.
Market Context
Clene Inc.'s stock currently trades at $4.14 with a market capitalization of $64.9M.
The 10-Q provides Clene Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Clene Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CLNN Stock Page
Frequently Asked Questions
Where can I read CLNN's SEC filings?
Browse all filings on our CLNN SEC filings page.
What types of SEC filings does Clene Inc. file?
Public companies like Clene Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.